Search filters

List of works by Anna Watson

A Novel Interaction Between Sympathetic Overactivity and Aberrant Regulation of Renin by miR-181a in BPH/2J Genetically Hypertensive Mice

scientific article published on 29 July 2013

Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice

scientific article

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

scientific article published on 3 December 2009

Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade

scientific article published in July 2005

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis

scientific article published on 22 October 2009

Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure

scientific article published on 6 February 2012

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice.

scientific article

Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species

scientific article published on 16 April 2019

E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta ⬇️

scientific article

Effect of central urotensin II on heart rate, blood pressure and brain Fos immunoreactivity in conscious rats

scientific journal article

Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex

scientific article

Leptin-target neurones of the rat hypothalamus express somatostatin receptors

scientific article published in September 2003

Linking RAGE and Nox in diabetic micro- and macrovascular complications

scientific article (publication date: September 2015)

Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture

scientific article published on 01 May 2018

Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.

scientific article published on 4 June 2014

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

scientific article published on 28 May 2008

Responses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheep

scientific article published on 16 July 2008

SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes Mellitus

scientific article published on 01 January 2019

Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep

scientific article published on 29 January 2004

The AGE/RAGE axis in diabetes-accelerated atherosclerosis.

scientific article published on March 2008

The emerging role of NADPH oxidase NOX5 in vascular disease

scientific article

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

scientific article published on 28 October 2009

The endothelin system and endothelin receptor antagonists

scientific article published on January 2012

The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat.

scientific article published in January 2002

The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy

scientific article published on 21 April 2017

Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions

scientific article (publication date: September 2003)

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes

scientific article published on 24 January 2013

Urotensin II, a novel peptide in central and peripheral cardiovascular control

scientific article published in October 2004

miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression ⬇️

scientific article

Paulina is supported by:

About Paulina

Help